sponsored links

Bone Drug Fails to Prevent Breast Cancer Recurrence: Study (HealthDay)

Sponsored Links

HealthDay – SUNDAY, Sept. 25 (HealthDay News) — The bone drug Zometa, once considered a promising weapon to reduce the risk of breast cancer recurrence, should not be used routinely in treatment of the disease, researchers say.

View full post on Yahoo! News: Health News


Sponsored Links
You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

AddThis Social Bookmark Button

Leave a Reply

You must be logged in to post a comment.